Cervicofacial hemangiomas treated from January 2001 to December 2009 was clinically evaluated. This retrospective clinical study consisted of 42 females and 20 males with the age ranged from 20 days to 55 years. The lesions were present with-in first month in 45 patients (72.6%). Two patterns of tumor growth were evident: focal and diffuse. There were 59 focal hemangiomas (80.8%) and 14 diffuse hemangiomas (19.2%).
Introduction
The most common congenital deformity observed in infants and children are the Cervico-facial Vascular anomalies. They frequently involve the head, neck, and Hemangioma is the most common tumor in infancy, with 3, 4 a perinatal incidence of 1% to 3% and affecting 10% of 5, 6 infants by one year of age . They are speculated to affect 5 4% to 12% of white children. The incidence seems to be lower in Asian infants and is low in children of African 7 decent . Up to 30% of preterm infants with low birth 8 weight (<1000g) may have hemangioma . A predilection for the female sex has been reported, [9] [10] [11] with a ratio of 2:1 to 5:1 . , intralesional and topical therapy ; sclerotherapy , 29 30,31 32 interferon α-2a , laser therapy , vincristine , 33 34,35 becaplermin gel , and β-blockers . Surgical treatment 36 includes intratumoral ligation , tobacco-pouch suture 37 38-45 technique , and excision . The question is how to identify those lesions that are most likely to require treatment and also which treatment modality is best suited for a particular individual. Therefore, a study that will characterize various features of hemangiomas, discussing various therapeutic options with emphasis on the timing of intervention, and also focusing on correlation between various managements of hemangiomas remains elusive. Table 2) .
Material and methods
Complications noted at the time of first consultation include residual skin changes in the form of fibro-fatty masses of tissue in 35 patients (56.5%). Obstruction of orifices was present in 14 patients (22.6%). They were the eye (3), mouth (5), and nose (6) . Ulceration was seen in 6 patients (9.7%). Infection occurred in 2 patients (3.2%) & was secondary to previous ulceration (Table 3) .
Management of the hemangiomas and mean age of treatment in each group is summarized in The aim of this study was to characterize hemangiomas depending upon the onset, gender distribution, anatomic location, and associated complications as well as to evaluate the treatment outcomes following various managements. The ratio of female to male in our group of patients was 2.1: 1, and was similar to the ratio 2, 9, 10, 11, 44 generally reported in the literature of 2:1 to 5:1 .
The age of these patients ranged from 20 days to 55 years with the average being 9 years and 6 months. Achauer et 44 al reported patients from 1 day to 59 years with the average age being 4 years and 7 months. The average age in present group was more because patients reported to our hospital after the complications had developed. Type  Group  Poor  Fair  Good  Excellent  Volume  I  2  3  4  2  II  1  3  3  2  III  2  6  8  6  IV  0  3  8  9  Color  I  1  3  7  0  II  2  1  5  1  III  0  11  7  4  IV  0  1  14  5  Texture  I  0  7  3  1  II  1  4  4  0  III  0  8  12  2  IV  0  4  13  3  Table 5 : Final outcome of the number of patients in each group
CERVICO-FACIAL HEMANGIOMAS; THE TREATMENT THAT ELUDES US
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Hemangiomas usually appear soon after birth in 60% to 2 70% of patients . In this study also, majority of the hemangiomas arise soon after birth within first month in 72.6% of patients. Thus, it can be concluded that infantile hemangioma usually arise after birth in majority. 46 Waner Obstruction of orifices was present in 14 patients (22.6%). They were the eye (3), mouth (5) , and nose (6).
Ulceration was seen in 6 patients (9.7%). Infection occurred in 2 patients (3.2%) and was secondary to previous ulceration. Thus, it can be concluded that obstruction and ulceration are the most common indication for management of hemangiomas during 16, 17 proliferative phase.
Our study showed that reduction in size of tumor in steroid treatment group was excellent in 2, good in 4, fair in 3, and poor in 2 patients. With regards to improvement in color good outcome was observed in 7, fair in 3, and poor in 1 patient. Improvement in texture was excellent in 6, good in 32, fair in 23, and only 1 patient had poor result. Also, the mean age of treatment in this group was 5 months. Hence, steroids resulted in improved outcome if treatment is recommended during proliferative [19] [20] [21] [22] [23] [24] [25] [26] [27] phase.
Most of the patients in our study received sclerotherapy, surgical treatment or combined approach, as they reported to us during involuting or involuted phase and with residual skin changes. In 9 patients who received sclerotherapy, reduction in volume was excellent in 2, good in 3, fair in 3, and poor in 1 patient. Improvement in color was excellent in 1, good in 5, fair in 1, and poor in 2 patients and improvement in texture was good in 4, fair in 4, and poor in 1 patient. The mean age of treatment in 28 this group was 12 years. In a study by Kane et al , sclerotherapy with sodium tetradecyl sulfate was used solely in 12 patients and resulted in a favorable outcome.
Surgery and combined modality approach resulted in improved outcome in majority of patients either in proliferative, involuting or involuted phase. This is similar 28 44 to studies done by Kane Therefore, treatment should be started early in the course of hemangioma as it will be more successful in preventing scarring, disfigurement, and life or function threatening sequelae and also in alleviating psychosocial burden of disease carried by the child and the family. It should, however be kept in mind that whatever action is undertaken should in no way result in a worse outcome than that which is seen with natural involution. 
Group II: Sclerotherapy
